Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed)
This Notice of Funding Opportunity (NOFO) solicits cooperative agreement research applications to support a multidisciplinary program titled "Accelerating Product Excellence in Innovation and for Clinical Adoption" (APEx), that will facilitate advancement of promising strategies
About this program
The Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) grant is designed to support projects that focus on improving the quality and effectiveness of products intended for clinical use. It aims to bridge the gap between innovation and practical application in healthcare settings. This grant is particularly beneficial for organizations and entities that are working on developing new healthcare products or technologies that require clinical validation and adoption. Eligible applicants include research institutions, healthcare organizations, and companies involved in the development of medical products. The grant encourages collaboration among various stakeholders in the healthcare ecosystem to ensure that innovative solutions are effectively integrated into clinical practice. By providing funding, the APEx grant seeks to accelerate the timeline for bringing new products to market and improving patient outcomes.
Eligibility
Research institutions, healthcare organizations, and companies involved in medical product development.